Preprint · OA
via OpenAlex
Mitophagy in cardiovascular diseases: mechanisms and potential therapies
Xinyu Hu, Shuhong Zhao, Dan Huang, Shiying Wang, Ying Xiong, Pan Wu, Hai-Jie Qi, Zhen-Guo Ma
· 2025
Abstract
Mitophagy, the selective autophagic degradation of mitochondria, is a critical process for preserving mitochondrial quality and cellular homeostasis in the cardiovascular system. This review systematically outlines the principal molecular mechanisms underlying mitophagy, focusing on the PTEN-induced putative kinase 1 (PINK1)-Parkin pathway and receptor-mediated pathways involving proteins such as BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3) and FUN14 domain-containing protein 1 (FUNDC1). In various cardiovascular diseases, mitophagy is complex and context dependent. When properly regulated, it exerts a protective role by clearing damaged mitochondria, mitigating oxidative stress, and suppressing inflammatory responses. However, the dysregulation of mitophagy—whether it is insufficient or excessive—can contribute to the exacerbation of disease progression. The therapeutic potential of modulating mitophagy through pharmacological agents, genetic interventions, and lifestyle changes is also examined. However, major challenges remain, including the dualistic nature of mitophagy outcomes, the lack of tissue-specific regulators, and the scarcity of clinically applicable modulators. Advancing our understanding of the multi-level regulatory networks governing mitophagy will be essential for developing targeted therapies to combat cardiovascular diseases (CVDs).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.22541/au.176368158.83446849/v1
- Canonical
- link ↗
- Fetched
- 2026-10-12 MST
Cite this
APA
Hu, X., Zhao, S., Huang, D., Wang, S., Xiong, Y., Wu, P., Qi, H., & Ma, Z. (2025). Mitophagy in cardiovascular diseases: mechanisms and potential therapies. https://doi.org/10.22541/au.176368158.83446849/v1
Vancouver
Hu X, Zhao S, Huang D, Wang S, Xiong Y, Wu P, et al. Mitophagy in cardiovascular diseases: mechanisms and potential therapies. 2025. doi:10.22541/au.176368158.83446849/v1.
BibTeX
@unpublished{xinyu2025Mitoph,
title = {Mitophagy in cardiovascular diseases: mechanisms and potential therapies},
author = {Xinyu Hu and Shuhong Zhao and Dan Huang and Shiying Wang and Ying Xiong and Pan Wu and Hai-Jie Qi and Zhen-Guo Ma},
year = {2025},
doi = {10.22541/au.176368158.83446849/v1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cardiovascular Diagnosis and Therapy 2026
Open access · CC-BY
Mitophagy in cardiovascular diseases: a literature review
npj Aging 2026
Open access · CC-BY
Targeting mitophagy for neuroprotection: mechanisms and therapeutic opportunities
Acta Biochimica Polonica 2007
Open access · CC-BY
Oxidative damage to DNA and antioxidant status in aging and age-related diseases.
International Journal of Environmental Sciences 2025
Open access · CC-BY
Metformin: Beyond Glycemic Control - A Comprehensive Review Of Its Adverse Effects And Emerging Therapeutic Potential
International journal of molecular sciences 2026
Open access · OA
Proteasome Dysfunction and Aggregation-Prone Proteins in Neurodegenerative Diseases: From Mechanisms to Therapeutic Opportunities.
International Journal of Molecular Sciences 2026
Open access · CC-BY